FDA Commissioner Marty Makary Resigns

Marty Makary, the U.S. Food and Drug Administration Commissioner, is stepping down from his position. Deputy Commissioner Kyle Diamantas will temporarily take over the leadership of the FDA. The announcement of Makary's resignation was reported by Politico, based on information from an administration official.


Devdiscourse News Desk | Updated: 12-05-2026 22:27 IST | Created: 12-05-2026 22:27 IST
FDA Commissioner Marty Makary Resigns
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.

In a significant leadership shift, U.S. Food and Drug Administration Commissioner Marty Makary has announced his resignation, according to a report by Politico.

The report, citing an administration official, revealed that Makary will officially step down on Tuesday. His departure marks the end of his tenure at the FDA.

Following Makary's resignation, Deputy Commissioner Kyle Diamantas is set to assume leadership of the organization in an acting capacity. This change comes at a pivotal time for the FDA, as it continues to navigate various regulatory challenges and advancements in medical science.

(With inputs from agencies.)

Give Feedback